======= PLEKHM2 ======= == Gene Information == * **Official Symbol**: PLEKHM2 * **Official Name**: pleckstrin homology and RUN domain containing M2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23207|23207]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8IWE5|Q8IWE5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PLEKHM2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PLEKHM2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609613|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein that binds the plus-end directed microtubule motor protein kinesin, together with the lysosomal GTPase Arl8, and is required for lysosomes to distribute away from the microtubule-organizing center. The encoded protein belongs to the multisubunit BLOC-one-related complex that regulates lysosome positioning. It binds a Salmonella effector protein called Salmonella induced filament A and is a critical host determinant in Salmonella pathogenesis. It has a domain architecture consisting of an N-terminal RPIP8, UNC-14, and NESCA (RUN) domain that binds kinesin-1 as well as the lysosomal GTPase Arl8, and a C-terminal pleckstrin homology domain that binds the Salmonella induced filament A effector protein. Naturally occurring mutations in this gene lead to abnormal localization of lysosomes, impaired autophagy flux and are associated with recessive dilated cardiomyopathy and left ventricular noncompaction. [provided by RefSeq, Feb 2017]. * **UniProt Summary**: N/A |RUN| |PH| |positive regulation of membrane tubulation| |regulation of membrane tubulation| |regulation of plasma membrane organization| |kinesin binding| |lysosome localization| |Golgi organization| |endosome membrane| |endomembrane system organization| |organelle localization| |regulation of protein localization| |positive regulation of cellular component organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|-1.9| |[[:results:exp425|Beta-Estradiol 0.55μM R07 exp425]]|-1.72| |[[:results:exp359|FK-506 30μM R07 exp359]]|-1.72| |[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|-1.71| |[[:results:exp223|Cabazitaxel 0.001μM R05 exp223]]|-1.7| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9557 * **Expression level (log2 read counts)**: 5.96 {{:chemogenomics:nalm6 dist.png?nolink |}}